HansBiomed USA, Inc

Form 483 issued November 8, 2022 · Englewood Cliffs, New Jersey

Inspection
Nov 7 – Nov 8, 2022
Investigator
Kwong P. Lee
Observations
4
Pages
4
FEI number
3008778066

In short: On November 8, 2022, FDA issued a Form 483 with 4 observations to HansBiomed USA, Inc in Englewood Cliffs, New Jersey (FEI 3008778066) after an inspection that ran Nov 7 – Nov 8, 2022. The investigator was Kwong P. Lee. Most observations concern cAPA and management controls; the most-cited regulation is 21 CFR 820.198 (complaint files).

At a glance

3 of 4 observations on this 483 concern capa.

CAPA3
Management controls1

What FDA observed

Preview: the opening words of each observation
  1. 01

    Written MDR procedures have…

  2. 02

    Procedures for receiving, reviewing, and evaluating complaints by a formally designated unit have…

  3. 03

    Quality audits were not performed at defined intervals to determine whether the quality system activities and…

  4. 04

    Records of complaint investigations do…

The full 483

Plus the full detail behind each one, exactly as FDA wrote it.

Get the full 483

This inspection in context

Questions about this 483

What did FDA find at HansBiomed USA, Inc?

FDA listed 4 observations on this Form 483, mostly about cAPA and management controls. The most-cited regulation is 21 CFR 820.198 (complaint files). The opening words of each observation are shown on this page.

Who inspected HansBiomed USA, Inc?

Kwong P. Lee is named on this Form 483, for the inspection of Nov 7 – Nov 8, 2022. Each investigator has a profile showing what they cite most.

When was HansBiomed USA, Inc inspected by FDA?

The inspection ran Nov 7 – Nov 8, 2022, and the Form 483 is dated November 8, 2022.

How do I get the full Form 483 for HansBiomed USA, Inc?

Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.

$99Get it free